🔥 Tuesday 21 July 2026 Tue, 21 July 2026
52 Big Stories
Telix Surpasses US$1 Billion Revenue Forecast as Clinical Trials Advance
Telix Pharmaceuticals reported a 21% year-on-year revenue jump to US$247 million in Q2 2026, buoyed by strong Precision Medicine sales and a new Regeneron partnership. The company also secured FDA alignment on a pivotal prostate cancer trial and expanded its manufacturing footprint.
21 July
Rox Resources Advances Youanmi Gold Project with Strong DFS and Full Funding
Rox Resources (ASX: RXL) is on track to become a significant gold producer with its Youanmi Gold Project, backed by a robust Definitive Feasibility Study and full funding. The project targets 117kozpa initially, with ambitions to surpass 150kozpa through ongoing exploration and development.
21 July
Alkane Resources Proposes Maiden Dividend After Record FY26 Production and Cash Flow
Alkane Resources capped FY26 with record production of 168,337 gold equivalent ounces and $174 million in quarterly cash flow, announcing a maiden fully franked dividend and setting robust FY27 guidance.
21 July
Contact Energy Reports Higher Sales and Lower Generation Costs in June 2026
Contact Energy's June 2026 operating report reveals rising electricity and gas sales alongside a sharp decline in generation costs and robust hydro storage. Renewable projects continue to advance, supporting the company’s clean energy ambitions.
21 July